255 related articles for article (PubMed ID: 21633716)
41. Vitreous metabolomics profiling of proliferative diabetic retinopathy.
Tomita Y; Cagnone G; Fu Z; Cakir B; Kotoda Y; Asakage M; Wakabayashi Y; Hellström A; Joyal JS; Talukdar S; Smith LEH; Usui Y
Diabetologia; 2021 Jan; 64(1):70-82. PubMed ID: 33099660
[TBL] [Abstract][Full Text] [Related]
42. Diabetes-induced oxidative stress in the vitreous humor.
Géhl Z; Bakondi E; Resch MD; Hegedűs C; Kovács K; Lakatos P; Szabó A; Nagy Z; Virág L
Redox Biol; 2016 Oct; 9():100-103. PubMed ID: 27454767
[TBL] [Abstract][Full Text] [Related]
43. The Level of Cytokines in the Vitreous Body of Severe Proliferative Diabetic Retinopathy Patients Undergoing Posterior Vitrectomy.
Raczyńska D; Lisowska KA; Pietruczuk K; Borucka J; Ślizień M; Raczyńska K; Glasner L; Witkowski JM
Curr Pharm Des; 2018; 24(27):3276-3281. PubMed ID: 30255745
[TBL] [Abstract][Full Text] [Related]
44. Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy.
Schwartzman ML; Iserovich P; Gotlinger K; Bellner L; Dunn MW; Sartore M; Grazia Pertile M; Leonardi A; Sathe S; Beaton A; Trieu L; Sack R
Diabetes; 2010 Jul; 59(7):1780-8. PubMed ID: 20424229
[TBL] [Abstract][Full Text] [Related]
45. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
[TBL] [Abstract][Full Text] [Related]
46. Plasma and aqueous humor angiotensin-converting enzyme levels in patients with diabetic retinopathy.
Aydin E; Demir HD; Sahin S
Curr Eye Res; 2010 Mar; 35(3):230-4. PubMed ID: 20373882
[TBL] [Abstract][Full Text] [Related]
47. Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Suzuki Y; Yao T; Okumura K; Seko Y; Kitano S
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1519-1525. PubMed ID: 31062144
[TBL] [Abstract][Full Text] [Related]
48. Association of serum and aqueous humor myonectin concentrations with diabetic retinopathy.
Sun H; Li Z; Hu W; Ma W
Sci Rep; 2021 Mar; 11(1):7215. PubMed ID: 33785845
[TBL] [Abstract][Full Text] [Related]
49. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
[TBL] [Abstract][Full Text] [Related]
50. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA
Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
[TBL] [Abstract][Full Text] [Related]
51. Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy.
Katome T; Namekata K; Mitamura Y; Semba K; Egawa M; Naito T; Harada C; Harada T
J Diabetes Complications; 2015 Mar; 29(2):275-81. PubMed ID: 25468312
[TBL] [Abstract][Full Text] [Related]
52. The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.
Yu Y; Zhang J; Zhu R; Zhao R; Chen J; Jin J; Tian Y; Su SB
Curr Mol Med; 2017 Dec; 17(4):280-286. PubMed ID: 29110608
[TBL] [Abstract][Full Text] [Related]
53. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients.
Liu Y; Luo L; He M; Liu X
Eye (Lond); 2004 Sep; 18(9):900-4. PubMed ID: 15017379
[TBL] [Abstract][Full Text] [Related]
54. Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
Izuta H; Matsunaga N; Shimazawa M; Sugiyama T; Ikeda T; Hara H
Mol Vis; 2010 Jan; 16():130-6. PubMed ID: 20142849
[TBL] [Abstract][Full Text] [Related]
55. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
56. Alteration of glutamine concentration in the vitreous humor in patients with proliferative vitreoretinopathy.
Ishikawa S; Nakazawa M; Ishikawa A; Ishiguro S; Tamai M
Curr Eye Res; 1995 Mar; 14(3):191-7. PubMed ID: 7796602
[TBL] [Abstract][Full Text] [Related]
57. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.
Wang H; Feng L; Hu J; Xie C; Wang F
Exp Eye Res; 2013 Mar; 108():110-9. PubMed ID: 23276812
[TBL] [Abstract][Full Text] [Related]
58. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.
Wu F; Phone A; Lamy R; Ma D; Laotaweerungsawat S; Chen Y; Zhao T; Ma W; Zhang F; Psaras C; Stewart JM
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):26. PubMed ID: 32084272
[TBL] [Abstract][Full Text] [Related]
59. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
60. Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy.
Rodríguez-Carrizalez AD; Castellanos-González JA; Martínez-Romero EC; Miller-Arrevillaga G; Villa-Hernández D; Hernández-Godínez PP; Ortiz GG; Pacheco-Moisés FP; Cardona-Muñoz EG; Miranda-Díaz AG
J Diabetes; 2014 Mar; 6(2):167-75. PubMed ID: 23875878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
